NCT06289010

Brief Summary

The goal of this interventional study is to compare the baseline neural mechanisms and parenting in depressed and non-depressed children and to examine baseline neural mechanisms and parenting as predictors of Family-Focused Treatment for Childhood-Depression (FFT-CD) outcomes. The main questions it aims to answer are:

  • What are differences between depressed and non-depressed participants on baseline neural and parenting indicators?
  • Do baseline neural and parenting indicators predict response to FFT-CD?
  • Does change in parenting and neural functioning mediate change in depression from baseline to follow-up? Participants will:
  • complete baseline clinical measures
  • complete neuroimaging tasks via Functional Magnetic Resonance Imaging (fMR)
  • undergo a 12-session course of FFT-CD
  • complete follow up evaluations and neuroimaging

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
18mo left

Started Aug 2024

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Aug 2024Nov 2027

First Submitted

Initial submission to the registry

February 24, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 1, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

August 20, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2027

Last Updated

August 23, 2024

Status Verified

August 1, 2024

Enrollment Period

2.5 years

First QC Date

February 24, 2024

Last Update Submit

August 21, 2024

Conditions

Keywords

Neural MechanismsDepressionChildrenAdolescentFamily

Outcome Measures

Primary Outcomes (2)

  • Depression Treatment Response

    \>/= 50% reduction on Children's Depression Rating Scale-Revised (CDRS-R). Scores on this measure range from 17 to 113, and higher scores indicate greater depression severity.

    4 months (post-treatment)

  • Children's Self Report of Depressive Symptoms

    Children's Depression Inventory (CDI) is a 28-item self-report measure. Scores range from 0 to 54 with higher scores reflecting higher levels of symptoms.

    4 months

Secondary Outcomes (1)

  • Depression Remission

    4 months

Study Arms (1)

Depressed Group

EXPERIMENTAL

20 children with depression and their parents (40 participants total) will undergo a 12-session course of FFT-CD.

Behavioral: Family-Focused Treatment for Childhood-Depression (FFT-CD)

Interventions

This intervention includes 12 one-hour, in-person sessions. FFT-CD was designed to help families gain skills to combat depression and create ways of interacting that protect the child from the negative sequelae of stress. Within a broad psychoeducational framework, interpersonal factors impacting youth depression and the interplay of mood and interpersonal interactions are emphasized. Participants are taught to identify Upward Spirals - positive interactions fueling positive moods leading further upward - and Downward Spirals - negative interactions fueling negative moods leading further downward. The treatment rationale is "to stop downward spirals and to start upward spirals"; this idea provides a foundation for skills building to help the child and family better navigate stress. Handouts, role-playing, behavioral rehearsal, and homework assignments are all used to help shape behaviors.

Depressed Group

Eligibility Criteria

Age7 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children must:
  • Have a current DSM-5 diagnosis of MDD, Persistent DD, or DDNOS (based on K-SADS-PL) OR not meet criteria for any DSM-5 mental health diagnosis (based on K-SADS-PL)
  • Be ages 7-12
  • Be living with a parent(s) or guardian willing to participate
  • Be able and willing to provide informed consent/assent
  • Parent must:
  • Not be currently pregnant
  • Be able to read, understand consent forms, and provide consent on their child's behalf
  • Be the biological parent (or grandparent in parental role) of the participating child \& have lived with the child for more than 75% of the child's life.
  • All participants must:
  • Not have a disturbance that would interfere with participation such as autism spectrum disorder, psychosis, current substance dependence, current use of psychotropic medication, OCD, or MRI contraindication such as metal inside the body or claustrophobia
  • Be proficient in English

You may not qualify if:

  • Thought or other disturbance in the child that would interfere with the ability to participate in treatment or assessments (e.g., psychotic disorder, autism spectrum disorder, OCD, active substance abuse/dependence, intellectual disability, as assessed on KSADS-PL)
  • Severe conduct disorders in the child that threaten the home stability (e.g. juvenile justice or children's protective service involvement as assessed on KSADS-PL) due to the potential impact on retention
  • Youth or primary caregivers do not speak English
  • Either parent or child has contraindications for neuroimaging (e.g., claustrophobia, metal implants, braces, electronically, magnetically, or mechanically activated devices such as cochlear implants)
  • The child is on an antidepressant medication, as it may complicate neuroimaging interpretation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Boston University

Boston, Massachusetts, 02215, United States

RECRUITING

Athinoula A. Martinos Imaging Center at Massachusetts Institute of Technology

Charlestown, Massachusetts, 02129, United States

RECRUITING

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Central Study Contacts

Martha C Tompson, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2024

First Posted

March 1, 2024

Study Start

August 20, 2024

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

November 1, 2027

Last Updated

August 23, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

These are initial pilot data and will not be shared at this time.

Locations